FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for BENLYSTA (belimumab) submitted by GlaxoSmithKline LLC. The snippet does not specify the exact changes to labeling or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

SUPPL AP for BENLYSTA (BELIMUMAB)